Head-to-head · WeighScore
Mondae vs OrderlyMeds
The verdict
Mondae takes it — 74.3/100 to 67/100.
Mondae grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mondae sells both molecules at some of the lowest figures in this ranking, bills every 28 days, and names a pharmacy on every product page except the two that matter.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Mondae | OrderlyMeds |
|---|---|---|
| WeighScore | 74.3/100 | 67/100 |
| Grade | C | C |
| Site position | #70 | #192 |
| Semaglutide | $87 per 28 days (thirteen charges a year; $75/mo requires a three-month prepay) | $74/mo (starting dose, 2-mo starter plan, new patients only, compounded) |
| Tirzepatide | $126 per 28 days (thirteen charges a year; $124/mo requires a three-month prepay) | $299/mo (compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Site position #70 · C
Strengths
- $87 and $126 per cycle are at the low end of what this ranking records for either molecule
- No membership or consultation fee is charged, stated on the checkout itself rather than in marketing copy
- Free shipping, and support hours are published as 8:00 AM to 8:00 PM Eastern
- A priced injectable peptide menu sits beside the GLP-1 lines
Where it loses points
- A Mondae month is 28 days — the intake says shipped and billed every 28 days, which is thirteen charges a year
- The homepage figures “from $75” and “from $124” are three-month prepay rates; the month-to-month rates are $87 and $126
- The hero reads “prices start from $87” above a grid whose lowest figure is $63
- The peptide rows are labeled billed monthly under three-month rates
- A pharmacy, Greenwich, is named on the sermorelin, NAD+ and glutathione pages and on neither GLP-1 page — the compounder for the drug this row is about is not disclosed
- No clinician, medical group or NPI is named; the Terms name a telehealth platform only
- Shipping is quoted at about two days in the plan FAQ and five to seven business days in the shipping policy
Site position #192 · C
FDAWarning letter issued to OrderlyMeds LLC dba OrderlyMeds in June 2026. See the FDA warning-letter database.
Strengths
- The starter rate and the standing rate are both published, so the step-up is visible before signing up
- No membership fees and no hidden costs, stated as such
- The dose ladder is published: four weeks at 0.25 mg then four weeks at 0.5 mg
- Brand-name routes are priced openly, at retail
Where it loses points
- The $74 rate is a two-month starter plan billed as $149 up front, and it is open only to patients new to GLP-1 medication; the standing monthly rate is $149
- Tirzepatide has no equivalent standing discount — $299/mo is the ongoing rate
- Brand-name routes are priced at retail: Wegovy $1,839 and Zepbound $1,498
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
- FDA issued OrderlyMeds LLC dba OrderlyMeds a warning letter in June 2026; the letter is public in FDA's warning-letter database
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.